Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136


Second primary malignancies following thyroid cancer: a population-based study in Taiwan.

Lu CH, Lee KD, Chen PT, Chen CC, Kuan FC, Huang CE, Chen MF, Chen MC.

Eur J Endocrinol. 2013 Oct 1;169(5):577-85. doi: 10.1530/EJE-13-0309. Print 2013 Nov.


Increased risk of second primary malignancies following uterine cancer: a population-based study in Taiwan over a 30-year period.

Lee KD, Chen CY, Huang HJ, Wang TY, Teng D, Huang SH, Lai CH, Chen MC.

BMC Cancer. 2015 May 11;15:393. doi: 10.1186/s12885-015-1426-3.


Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan.

Lee YT, Liu CJ, Hu YW, Teng CJ, Tzeng CH, Yeh CM, Chen TJ, Lin JK, Lin CC, Lan YT, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC, Chang SC, Chen MH, Teng HW, Liu JH, Yen CC.

Medicine (Baltimore). 2015 Jul;94(26):e1079. doi: 10.1097/MD.0000000000001079.


Italian cancer figures, report 2013: Multiple tumours.

AIRTUM Working Group..

Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. English, Italian.


Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period.

Chen CY, Lai CH, Lee KD, Huang SH, Dai YM, Chen MC.

Gynecol Oncol. 2012 Dec;127(3):625-30. doi: 10.1016/j.ygyno.2012.09.004. Epub 2012 Sep 10.


Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.

Teng CJ, Hu YW, Chen SC, Yeh CM, Chiang HL, Chen TJ, Liu CJ.

J Natl Cancer Inst. 2015 Nov 3;108(2). pii: djv314. doi: 10.1093/jnci/djv314. Print 2016 Feb.


Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.

Lee KD, Chen SC, Chan CH, Lu CH, Chen CC, Lin JT, Chen MF, Huang SH, Yeh CM, Chen MC.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2647-55. doi: 10.1158/1055-9965.EPI-08-0109.


Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: a nationwide population-based study.

Chen SC, Teng CJ, Hu YW, Yeh CM, Hung MH, Hu LY, Ku FC, Tzeng CH, Chiou TJ, Chen TJ, Liu CJ.

PLoS One. 2015 Jan 30;10(1):e0116384. doi: 10.1371/journal.pone.0116384. eCollection 2015.


Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.

Hisada M, Chen BE, Jaffe ES, Travis LB.

J Natl Cancer Inst. 2007 Feb 7;99(3):215-22.


Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.

Chien SH, Liu CJ, Hong YC, Teng CJ, Hu YW, Ku FC, Yeh CM, Chiou TJ, Gau JP, Tzeng CH.

J Cancer Res Clin Oncol. 2015 Nov;141(11):1995-2004. doi: 10.1007/s00432-015-1979-1. Epub 2015 May 14.


Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis.

Subramanian S, Goldstein DP, Parlea L, Thabane L, Ezzat S, Ibrahim-Zada I, Straus S, Brierley JD, Tsang RW, Gafni A, Rotstein L, Sawka AM.

Thyroid. 2007 Dec;17(12):1277-88. Review.


The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.

Guan X, Jin Y, Chen Y, Jiang Z, Liu Z, Zhao Z, Yan P, Wang G, Wang X.

PLoS One. 2015 Nov 16;10(11):e0143067. doi: 10.1371/journal.pone.0143067. eCollection 2015.


Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study.

Hung MH, Liu CJ, Teng CJ, Hu YW, Yeh CM, Chen SC, Chien SH, Hung YP, Shen CC, Chen TJ, Tzeng CH, Liu CY.

PLoS One. 2016 Feb 19;11(2):e0148597. doi: 10.1371/journal.pone.0148597. eCollection 2016.


Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.

Spanogle JP, Clarke CA, Aroner S, Swetter SM.

J Am Acad Dermatol. 2010 May;62(5):757-67. doi: 10.1016/j.jaad.2009.07.039. Epub 2010 Mar 12.


Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan.

Chen SC, Liu CJ, Hu YW, Yeh CM, Hu LY, Wang YP, Hung YP, Tzeng CH, Chiou TJ, Chen TJ, Teng CJ.

Gastric Cancer. 2016 Apr;19(2):490-7. doi: 10.1007/s10120-015-0482-3. Epub 2015 Mar 13.


Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.

Cho YY, Lim J, Oh CM, Ryu J, Jung KW, Chung JH, Won YJ, Kim SW.

Cancer. 2015 Jan 15;121(2):259-68. doi: 10.1002/cncr.29025. Epub 2014 Sep 15.


Thyroid malignancies in survivors of Hodgkin lymphoma.

Michaelson EM, Chen YH, Silver B, Tishler RB, Marcus KJ, Stevenson MA, Ng AK.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):636-41. doi: 10.1016/j.ijrobp.2013.11.237.


The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979-2003).

Chen MC, Feng IJ, Lu CH, Chen CC, Lin JT, Huang SH, Lee KD.

Ann Oncol. 2008 Jun;19(6):1180-6. doi: 10.1093/annonc/mdn003. Epub 2008 Jan 30.


Increased risk of certain second primary malignancies in patients treated for well-differentiated thyroid cancer.

Hakala TT, Sand JA, Jukkola A, Huhtala HS, Metso S, Kellokumpu-Lehtinen PL.

Int J Clin Oncol. 2016 Apr;21(2):231-9. doi: 10.1007/s10147-015-0904-6. Epub 2015 Sep 26.


Co-occurrence of second primary malignancy in patients with thyroid cancer.

Hsu CH, Huang CL, Hsu YH, Iqbal U, Nguyen PA, Jian WS.

QJM. 2014 Aug;107(8):643-8. doi: 10.1093/qjmed/hcu051. Epub 2014 Mar 11.


Supplemental Content

Support Center